atrial-fibrillation

Documents about atrial-fibrillation

• A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)#847104ClinicalTrials.gov
• The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation#852363ClinicalTrials.gov
• Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction#859604ClinicalTrials.gov
• FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation#884255ClinicalTrials.gov
• Contact Force Sensing and Pulmonary Vein Isolation#891424ClinicalTrials.gov
• Management of New-Onset Postoperative Atrial Fibrillation#891866ClinicalTrials.gov
• Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study#893833ClinicalTrials.gov
• Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation#895379ClinicalTrials.gov
• Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation#896279ClinicalTrials.gov
• The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation#904544ClinicalTrials.gov
• Pulmonary Vein Isolation Using Stereotactic Radiotherapy System for the Treatment of Refractory Atrial Fibrillation#905275ClinicalTrials.gov
• Predicting Risk of Atrial Fibrillation and Association With Other Diseases#910272ClinicalTrials.gov
• A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter#911066ClinicalTrials.gov
• Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function#857269ClinicalTrials.gov
• A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan#886482ClinicalTrials.gov
• Therapy of Atrial Flutter by Afib Ablation#851785ClinicalTrials.gov
• Left Atrial Appendage Occlusion Study II#871435ClinicalTrials.gov
• Atrial Pressure Electrophysiology Pilot Study#836232ClinicalTrials.gov
• Canadian WATCHMAN Registry#887737ClinicalTrials.gov
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)#825677ClinicalTrials.gov
• Patient Convenience Study (RE-SONANCE)#146299ClinicalTrials.gov
• CLOSE to CURE Study#174979ClinicalTrials.gov
• Clinical codelist - Atrial fibrillation - CPRD Aurum#280747LSHTM Data Compass
• Cryo Global Registry#868760ClinicalTrials.gov
• Affera Global Registry#868812ClinicalTrials.gov
• European CURE-AF Study#878919ClinicalTrials.gov
• Anticoagulation After RFCA#882300ClinicalTrials.gov
• Conscious Sedation Study#897141ClinicalTrials.gov
• Low Fluoroscopy Afib Ablation Registry#904228ClinicalTrials.gov
• Electrocardiogram Clinical Validation Study#917913ClinicalTrials.gov
• Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease#908297ClinicalTrials.gov
• Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)#474824ClinicalTrials.gov
• COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2#830993ClinicalTrials.gov
• Sensitivity and Specificity of a Mobile Lead-one ECG Like Device for the Detection of Atrial Fibrillation (AF)#840533ClinicalTrials.gov
• Effect of Remote Ischemic Preconditioning on Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery#845947ClinicalTrials.gov
• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease#846740ClinicalTrials.gov
• COlchicine in Cardiac Surgery#855363ClinicalTrials.gov
• Vektor vMap™ Clinical Validation Study#872832ClinicalTrials.gov
• Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation#879029ClinicalTrials.gov
• Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke#879558ClinicalTrials.gov
• Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation#888186ClinicalTrials.gov
• Virtual for Care Atrial Fibrillation Patients Using VIRTUES#892183ClinicalTrials.gov
• A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.#916565ClinicalTrials.gov
• Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon#966992ClinicalTrials.gov
• Explainable detection of spatio-temporal dispersion in multipolar intracardiac electrograms for patient-tailored catheter ablation of persistent atrial fibrillation#126744HAL (France)
• Beyond CHA²DS²-VASc: Hemodynamic and Morphologic Discriminants for Thrombus Formation and Stroke in Atrial Fibrillation Patients#231683HAL (France)
• The Effect of Pulse Field Ablation of Atrial Fibrillation Involving Posterior Wall Ablation on Atrial Mechancis Assessed by Cardiac Magnetic Resonance Imaging#859597ClinicalTrials.gov
• Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation#676447Europe PMC
• A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery#824867ClinicalTrials.gov
• Electronic Clinical Decision Support System (eCDSS) for Prevention of Atrial Fibrillation-related Stroke#892755ClinicalTrials.gov